An-Najah Center for Cancer and Stem Cell Research
Cancer and regenerative medicine are key research targets that will radically change medical treatments.
An-Najah Center for Cancer and Stem Cell Research conducts basic, translational, and clinical research to develop novel drugs to make the body kill cancer and to develop optimal conditions to regrow, repair or replace damaged or diseased cells, organs or tissues.
Our goals:
Identify the critical genes and pathways that distinguish cancer from normal (stem) cells, isolate tissue-specific stem cells and define the conditions that are required to repair damaged tissues, develop novel drugs for cancer therapy and regenerative medicine, fix defective, disease-causing genes (gene therapy) and regrowth of damaged tissues (body parts).
Our ultimate goal is to translate our discoveries into clinical trials (from Bench to Bedside). We want to work in tandem with our academic and industry colleagues to share discoveries made here as broadly as possible.